S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
Retirement Plans in 2023: Choosing the Right Account
The Biggest "Missing Ingredient" in the $7 Trillion EV Market (Ad)
Bed Bath & Beyond Is Circling the Drain
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
The Biggest "Missing Ingredient" in the $7 Trillion EV Market (Ad)
AMD Results Are No Reason To Buy Semiconductors... Yet
Scotts Miracle-Gro Hits Bottom, Reversal In Play
The Biggest "Missing Ingredient" in the $7 Trillion EV Market (Ad)
Altria is a Great Recession Stock, Long-Term Outlook Uncertain
Closing prices for crude oil, gold and other commodities
S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
Retirement Plans in 2023: Choosing the Right Account
The Biggest "Missing Ingredient" in the $7 Trillion EV Market (Ad)
Bed Bath & Beyond Is Circling the Drain
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
The Biggest "Missing Ingredient" in the $7 Trillion EV Market (Ad)
AMD Results Are No Reason To Buy Semiconductors... Yet
Scotts Miracle-Gro Hits Bottom, Reversal In Play
The Biggest "Missing Ingredient" in the $7 Trillion EV Market (Ad)
Altria is a Great Recession Stock, Long-Term Outlook Uncertain
Closing prices for crude oil, gold and other commodities
S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
Retirement Plans in 2023: Choosing the Right Account
The Biggest "Missing Ingredient" in the $7 Trillion EV Market (Ad)
Bed Bath & Beyond Is Circling the Drain
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
The Biggest "Missing Ingredient" in the $7 Trillion EV Market (Ad)
AMD Results Are No Reason To Buy Semiconductors... Yet
Scotts Miracle-Gro Hits Bottom, Reversal In Play
The Biggest "Missing Ingredient" in the $7 Trillion EV Market (Ad)
Altria is a Great Recession Stock, Long-Term Outlook Uncertain
Closing prices for crude oil, gold and other commodities
S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
Retirement Plans in 2023: Choosing the Right Account
The Biggest "Missing Ingredient" in the $7 Trillion EV Market (Ad)
Bed Bath & Beyond Is Circling the Drain
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
The Biggest "Missing Ingredient" in the $7 Trillion EV Market (Ad)
AMD Results Are No Reason To Buy Semiconductors... Yet
Scotts Miracle-Gro Hits Bottom, Reversal In Play
The Biggest "Missing Ingredient" in the $7 Trillion EV Market (Ad)
Altria is a Great Recession Stock, Long-Term Outlook Uncertain
Closing prices for crude oil, gold and other commodities
NASDAQ:TRIB

Trinity Biotech - TRIB Stock Forecast, Price & News

$1.10
+0.02 (+1.86%)
(As of 02/1/2023 12:00 AM ET)
Add
Compare
Today's Range
$1.05
$1.10
50-Day Range
$0.96
$1.35
52-Week Range
$0.86
$1.55
Volume
7,909 shs
Average Volume
21,043 shs
Market Capitalization
$41.73 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Trinity Biotech MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.16% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.96mentions of Trinity Biotech in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.71) to ($0.04) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.50 out of 5 stars

Medical Sector

950th out of 1,030 stocks

Diagnostic Substances Industry

14th out of 16 stocks


TRIB stock logo

About Trinity Biotech (NASDAQ:TRIB) Stock

Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. It operates through the Americas and Rest of World geographical segments. The company was founded by Ronan O'Caoimh and Denis R. Burger in June 1992 and is headquartered in Bray, Ireland.

Receive TRIB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter.

TRIB Stock News Headlines

Trinity Biotech plc (NASDAQ:TRIB) Short Interest Update
The Biggest "Missing Ingredient" in the $7 Trillion EV Market
China has owned the graphite market for decades. But the U.S. just added graphite to a list of super-critical minerals... "essential for America's National Defense." Perfect timing for a "made in America" graphite company looking to mine, manufacture, and recycle graphite for the booming electric car market.
Profit From the Commercial Solar Boom?
Solar energy had its best year ever in 2021, with a record 24 gigawatts of power installed. That's enough to power 18 million homes! Analysts expect the global solar farm market to reach $356 billion by 2028. The utility segment of the solar market is expected to grow at the highest annual growth rate in the industry, especially with the many tax incentives now offered.
Here's what Wall Street expects from Trinity Biotech's earnings
Trinity Biotech Announces Q3 2022 Financial Results
Trinity Biotech's Earnings: A Preview
TRIB Trinity Biotech plc
Trinity Biotech Announces Results of AGM
See More Headlines
Receive TRIB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter.

TRIB Company Calendar

Last Earnings
12/15/2022
Today
2/02/2023
Next Earnings (Estimated)
4/10/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Diagnostic substances
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:TRIB
Employees
543
Year Founded
1992

Profitability

Net Income
$880,000.00
Pretax Margin
-30.60%

Debt

Sales & Book Value

Annual Sales
$92.96 million
Cash Flow
$0.58 per share
Book Value
($0.02) per share

Miscellaneous

Free Float
34,983,000
Market Cap
$41.73 million
Optionable
Optionable
Beta
1.42

Social Links


Key Executives

  • Aris Kekedjian
    Chairman & Chief Executive Officer
  • John Gillard
    CFO, Secretary & Executive Director
  • Eibhlin Kelly
    Chief Information Officer
  • Terence Dunne
    Director-Business Development
  • Fernando Devia
    Executive Vice President-Sales













TRIB Stock - Frequently Asked Questions

How have TRIB shares performed in 2023?

Trinity Biotech's stock was trading at $0.99 on January 1st, 2023. Since then, TRIB shares have increased by 10.6% and is now trading at $1.0950.
View the best growth stocks for 2023 here
.

Are investors shorting Trinity Biotech?

Trinity Biotech saw a decline in short interest in the month of January. As of January 15th, there was short interest totaling 60,600 shares, a decline of 19.8% from the December 31st total of 75,600 shares. Based on an average trading volume of 33,600 shares, the days-to-cover ratio is currently 1.8 days.
View Trinity Biotech's Short Interest
.

When is Trinity Biotech's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, April 10th 2023.
View our TRIB earnings forecast
.

How were Trinity Biotech's earnings last quarter?

Trinity Biotech plc (NASDAQ:TRIB) posted its quarterly earnings data on Thursday, December, 15th. The company reported ($0.18) earnings per share for the quarter, missing the consensus estimate of ($0.04) by $0.14. The business had revenue of $19.50 million for the quarter, compared to analysts' expectations of $19.50 million. Trinity Biotech had a negative trailing twelve-month return on equity of 419.23% and a negative net margin of 42.21%.

What guidance has Trinity Biotech issued on next quarter's earnings?

Trinity Biotech updated its third quarter 2022 earnings guidance on Thursday, November, 10th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $19.00 million-$20.00 million.

What is Ronan O'Caoimh's approval rating as Trinity Biotech's CEO?

20 employees have rated Trinity Biotech Chief Executive Officer Ronan O'Caoimh on Glassdoor.com. Ronan O'Caoimh has an approval rating of 8% among the company's employees. This puts Ronan O'Caoimh in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Trinity Biotech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Trinity Biotech investors own include Gilead Sciences (GILD), Novavax (NVAX), OPKO Health (OPK), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Netflix (NFLX), Pfizer (PFE), QUALCOMM (QCOM), Energy Transfer (ET) and Exxon Mobil (XOM).

What is Trinity Biotech's stock symbol?

Trinity Biotech trades on the NASDAQ under the ticker symbol "TRIB."

Who are Trinity Biotech's major shareholders?

Trinity Biotech's stock is owned by a number of institutional and retail investors. Top institutional investors include Hunter Associates Investment Management LLC (4.79%) and Concourse Financial Group Securities Inc. (0.00%).

How do I buy shares of Trinity Biotech?

Shares of TRIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Trinity Biotech's stock price today?

One share of TRIB stock can currently be purchased for approximately $1.10.

How much money does Trinity Biotech make?

Trinity Biotech (NASDAQ:TRIB) has a market capitalization of $41.73 million and generates $92.96 million in revenue each year. The company earns $880,000.00 in net income (profit) each year or ($1.09) on an earnings per share basis.

How many employees does Trinity Biotech have?

The company employs 543 workers across the globe.

How can I contact Trinity Biotech?

Trinity Biotech's mailing address is IDA BUSINESS PARK BRAY, WICKLOW L2, . The official website for the company is www.trinitybiotech.com. The company can be reached via phone at (531) 276-9800, via email at kevin.tansley@trinitybiotech.com, or via fax at 353-1276-9888.

This page (NASDAQ:TRIB) was last updated on 2/2/2023 by MarketBeat.com Staff